ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,037.29
-0.32%
Gold vs US Dollar
2,325.125
-0.11%
Brent Oil
84.795
-0.73%
Bitcoin
60,269.04
-2.18%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Nexalin Technologies Inc (NXLIW) Share Price

NXLIW Nexalin Technologies Inc

0.29
-0.11 (-27.50%)
Last Updated: 19:35:39
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Nexalin Technologies Inc NASDAQ:NXLIW NASDAQ Equity Warrant  Warrant
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.11 -27.50 0.29 0.29 0.32 0.40 0.26 0.4 2,791 18:35:39   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Electromedical Apparatus 111k -4.65M -0.6251 -2.80 13.01M
 Type  Size  Price  Time  Units 
 6 100 0.29 18:35:39 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore NXLIW News
28/06/202402:15GLOBENexalin Technology Announces Pricing of $5.2 Million Public Offering
26/06/202414:00GLOBENexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal
20/06/202413:30GLOBENexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia
18/06/202422:02EDGAR2Form 8-K - Current report
14/06/202414:53EDGAR2Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
13/06/202420:00GLOBENexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
12/06/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for NXLIW

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Nexalin Technologies Inc Articles